跳至主要内容
临床试验/NCT01657877
NCT01657877已完成2 期

In Situ Study to Confirm the Anti-caries Potential of a 1.1365% w/w Sodium Monofluorophosphate (1500ppm F) Dentifrice

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Percentage (%) Change in Surface Microhardness (SMH) Following 21 Days of Twice Daily Treatment With the 1500 Ppm Fluoride + 5% CSP Dentifrice and With the 1500 Ppm Fluoride Dentifrice.

研究概览

简要总结

In situ study to compare treatment effect on enamel remineralization potential, measured by surface microhardness recovery (SMHR) and Enamel Fluoride Uptake (EFU). The study will explore the efficacy of an experimental sodium monofluorophosphate (SMFP) dentifrice containing calcium sodium phosphosilicate (CSP) in comparison to an experimental SMFP only dentifrice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Wears a removable bilateral mandibular partial denture that has good stability and support, with sufficient room on each side in the posterior buccal flange area to accommodate two enamel specimens [required dimensions 12 x 7 millimeters (mm)].

排除标准

  • 未提供

研究组 & 干预措施

CSP/SMFP Dentifrice

Experimental

Dentifrice containing high fluoride content as SMFP and CSP

干预措施: Calcium sodium phosphosilicate (Drug)

CSP/SMFP Dentifrice

Experimental

Dentifrice containing high fluoride content as SMFP and CSP

干预措施: Sodium monoflurophosphate (Drug)

SMFP Dentifrice Prototype 1

Active Comparator

Dentifrice containing high fluoride content as SMFP and no CSP

干预措施: Sodium monoflurophosphate (Drug)

SMFP Dentifrice Prototype 2

Active Comparator

Dentifrice containing low fluoride content as SMFP and no CSP

干预措施: Sodium monoflurophosphate (Drug)

CSP Dentifrice

Active Comparator

Dentifrice containing CSP but no fluoride

干预措施: Calcium sodium phosphosilicate (Drug)

Placebo Dentifrice

Placebo Comparator

Dentifrice containing no CSP and no fluoride

干预措施: Placebo (Drug)

结局指标

主要结局

Percentage (%) Change in Surface Microhardness (SMH) Following 21 Days of Twice Daily Treatment With the 1500 Ppm Fluoride + 5% CSP Dentifrice and With the 1500 Ppm Fluoride Dentifrice.

时间窗: Baseline to 21 days

Percent SMH recovery (SMHR) was calculated from hardness values of enamel specimens at baseline (B), after in-situ hardening (R) and after first demineralization challenge (D1) using formula: \[(D1-R)/ (D1-B)\]\*100. A greater percentage change in SMHR represents a better remineralisation and hence a better outcome.

次要结局

  • Percentage (%) Change in SMH Following 21 Days of Twice Daily Treatment With 500 Ppm Fluoride as SMFP and 0 % CSP Dentifrice, 0 Ppm Fluoride and 0% CSP, and 0 Ppm Fluoride and 5 % CSP.(Baseline to 21 days)
  • Enamel Fluoride Uptake (EFU)(Baseline to 21 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验